Terlipressin Administration Strategies in Hepatorenal Syndrome–Acute Kidney Injury - Ep 150

Dr. Jason Yerke summarizes current evidence from clinical trials and comparative studies evaluating terlipressin continuous infusion versus intermittent bolus dosing strategies, with a focus on efficacy, safety, and operational considerations. Read the full-text manuscript: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70084.